Indian Tobramycin Exporters: Complete Supplier Ranking with Market Share — 580 Manufacturers (2026) — TransData Nexus

Q: Who is the largest tobramycin buyer importing from India?

LIFESTAR PHARMA LLC (UNITED STATES) is the largest tobramycin importer from India with a 12.8% market share and import value of $5.0M.

Q: How many tobramycin buyers import from India?

There are 580 active tobramycin buyers importing from India, with a combined import market of $39.2M across 2,676 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top tobramycin buyers from India?

The top 5 tobramycin buyers — LIFESTAR PHARMA LLC, EVERSANA LIFE SCIENCE SERVICES, LLC SENTISS RUS, YUSEN LOGISTICS BENELUX BELGIUM, RX CROSSROADS 3PL LLC — together control 45.6% of total tobramycin import value from India.

Suresh Sormare

Tobramycin

India Pharmaceutical Trade Intelligence

$39.2M283 Suppliers134 CountriesHS 30049099

ExportsIndia → UNITED STATES62.3%India → RUSSIA15.3%

ImportsUNITED STATES → India$498.0K CHINA → India$88.3K

#1 Supplier: MANKIND PHARMA #1 Buyer: LIFESTAR PHARMA

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $24.5M through 239 shipments. This represents a market share of 62.3% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• LIFESTAR PHARMA LLC - $5.0M (20.6% of country's total business)

• EVERSANA LIFE SCIENCE SERVICES - $4.3M (17.5% of country's total business)

• RX CROSSROADS 3PL LLC - $2.0M (8.2% of country's total business)

• SUN PHARMACEUTICAL INDUSTRIES,INC. - $1.5M (6.2% of country's total business)

• SUN PHARMACEUTICAL INDUSTRIES INC - $1.3M (5.2% of country's total business)

• Rest of United States's importers - $10.4M (42.4% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $102.4K, indicating premium pricing strategy compared to the market average of $14.7K.

United States is a key market for Tobramycin imports, representing 62.3% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Tobramycin buyer market intelligence

1Buyer Segment Analysis

The 580 buyers of Tobramycin imported from India can be categorized into several segments:

Distributors: Entities like LIFESTAR PHARMA LLC and EVERSANA LIFE SCIENCE SERVICES in the United States fall into this category. They purchase large volumes to supply hospitals, pharmacies, and other healthcare providers. Their buying behavior is characterized by bulk orders and a focus on maintaining a consistent supply chain to meet market demand.

Contract Manufacturers: Companies such as SUN PHARMACEUTICAL INDUSTRIES INC. in the United States are contract manufacturers. They procure Tobramycin to produce finished pharmaceutical products, either for their own brands or on behalf of other companies. Their procurement patterns are aligned with production schedules and client demands, often involving large, periodic orders.

Re-exporters: Entities like YUSEN LOGISTICS BENELUX BELGIUM serve as intermediaries, importing Tobramycin for redistribution to other markets. Their purchasing behavior is influenced by global demand fluctuations and trade agreements, leading to variable order sizes and frequencies.

Government Procurement Agencies: While not explicitly listed among the top 10 buyers, government agencies in various countries procure Tobramycin through tenders to supply public healthcare facilities. Their buying patterns are typically characterized by large, infrequent orders based on national healthcare needs and budget allocations.

Country-Specific Import Regulations

TransData Nexus Tobramycin buyer market intelligence

1Country-Specific Import Regulations

Understanding the import regulations for Tobramycin in the top five importing countries is crucial for market entry and compliance:

1. United States

Regulatory Authority: Food and Drug Administration (FDA).

Import Registration Process: Importers must ensure that Tobramycin is FDA-approved. The process involves submitting a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) for generic products.

Estimated Timeline: The approval process can take approximately 10 months for an ANDA, though timelines may vary.

Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are generally duty-free in the U.S.

2. Russia

Regulatory Authority: Ministry of Health of the Russian Federation.

Import Registration Process: Requires state registration of the medicinal product, involving submission of a dossier, clinical trials, and quality assessments.

Demand Drivers & Market Opportunity

TransData Nexus Tobramycin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Tobramycin across various countries is driven by several factors:

Disease Prevalence: Tobramycin is primarily used to treat severe bacterial infections, including those caused by Pseudomonas aeruginosa, which is prevalent in hospital-acquired infections. The global rise in antibiotic-resistant infections has increased the reliance on aminoglycosides like Tobramycin.

Government Healthcare Programs: Many countries have implemented programs to combat antimicrobial resistance, leading to increased procurement of effective antibiotics. For instance, the WHO's AWaRe classification system, updated in 2019, categorizes antibiotics to guide appropriate use, with Tobramycin listed in the 'Watch' category, indicating its importance in treating specific infections. (who.int)

Universal Health Coverage Expansion: Countries expanding their healthcare coverage are increasing access to essential medicines, including antibiotics. This expansion leads to higher demand for medications like Tobramycin to treat bacterial infections.

WHO Essential Medicines List Procurement: Tobramycin's inclusion in the WHO Model List of Essential Medicines underscores its critical role in healthcare. This designation encourages countries to prioritize its procurement to ensure availability in public health systems. (who.int)

Common Questions — Tobramycin Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest tobramycin buyer importing from India?

Based on import volume and value, LIFESTAR PHARMA LLC (UNITED STATES) leads with $5.0M in imports and a 12.8% market share — the highest of any single tobramycin importer. EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) and LLC SENTISS RUS (RUSSIA) are the next largest buyers.

QHow many companies buy tobramycin from India?

There are 580 active tobramycin buyers importing from India, with a combined market of $39.2M across 2,676 shipments to 134 countries. The top 5 buyers hold 45.6% of total import value, while the remaining 575 buyers handle the other 54.4%.

QWhich countries import the most tobramycin from India?

The top importing countries for tobramycin from India are United States (62.3%), Russia (15.3%), Belgium (8.8%), Australia (4.0%), Vietnam (1.7%). These markets represent the largest demand centres for Indian pharmaceutical exports of tobramycin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for tobramycin from India?

The average import transaction value for tobramycin from India is $14.7K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Tobramycin buyer market intelligence

1Buyer Segment Analysis

The 580 buyers of Tobramycin imported from India can be categorized into several segments:

Distributors: Entities like LIFESTAR PHARMA LLC and EVERSANA LIFE SCIENCE SERVICES in the United States fall into this category. They purchase large volumes to supply hospitals, pharmacies, and other healthcare providers. Their buying behavior is characterized by bulk orders and a focus on maintaining a consistent supply chain to meet market demand.

Contract Manufacturers: Companies such as SUN PHARMACEUTICAL INDUSTRIES INC. in the United States are contract manufacturers. They procure Tobramycin to produce finished pharmaceutical products, either for their own brands or on behalf of other companies. Their procurement patterns are aligned with production schedules and client demands, often involving large, periodic orders.

Re-exporters: Entities like YUSEN LOGISTICS BENELUX BELGIUM serve as intermediaries, importing Tobramycin for redistribution to other markets. Their purchasing behavior is influenced by global demand fluctuations and trade agreements, leading to variable order sizes and frequencies.

Government Procurement Agencies: While not explicitly listed among the top 10 buyers, government agencies in various countries procure Tobramycin through tenders to supply public healthcare facilities. Their buying patterns are typically characterized by large, infrequent orders based on national healthcare needs and budget allocations.

Country-Specific Import Regulations

TransData Nexus Tobramycin buyer market intelligence

1Country-Specific Import Regulations

Understanding the import regulations for Tobramycin in the top five importing countries is crucial for market entry and compliance:

1. United States

Regulatory Authority: Food and Drug Administration (FDA).

Estimated Timeline: The approval process can take approximately 10 months for an ANDA, though timelines may vary.

Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are generally duty-free in the U.S.

2. Russia

Regulatory Authority: Ministry of Health of the Russian Federation.

Import Registration Process: Requires state registration of the medicinal product, involving submission of a dossier, clinical trials, and quality assessments.

Demand Drivers & Market Opportunity

TransData Nexus Tobramycin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Tobramycin across various countries is driven by several factors:

Disease Prevalence: Tobramycin is primarily used to treat severe bacterial infections, including those caused by Pseudomonas aeruginosa, which is prevalent in hospital-acquired infections. The global rise in antibiotic-resistant infections has increased the reliance on aminoglycosides like Tobramycin.

Government Healthcare Programs: Many countries have implemented programs to combat antimicrobial resistance, leading to increased procurement of effective antibiotics. For instance, the WHO's AWaRe classification system, updated in 2019, categorizes antibiotics to guide appropriate use, with Tobramycin listed in the 'Watch' category, indicating its importance in treating specific infections. (who.int)

Universal Health Coverage Expansion: Countries expanding their healthcare coverage are increasing access to essential medicines, including antibiotics. This expansion leads to higher demand for medications like Tobramycin to treat bacterial infections.

WHO Essential Medicines List Procurement: Tobramycin's inclusion in the WHO Model List of Essential Medicines underscores its critical role in healthcare. This designation encourages countries to prioritize its procurement to ensure availability in public health systems. (who.int)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Tobramycin

Tobramycin

Who Buys Tobramycin from India — 580 Importers Behind a $39.2M Market

Top Tobramycin Importers — Ranked by Import Value

Top Tobramycin Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Tobramycin — and from which countries?

Tobramycin — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Tobramycin Buyers & Importers

QWho is the largest tobramycin buyer importing from India?

QHow many companies buy tobramycin from India?

QWhich countries import the most tobramycin from India?

QWhat is the average import order value for tobramycin from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Russia

3Belgium

4Australia

5Vietnam

Analysis Methodology